HeartSciences Inc. Common Stock earnings per share and revenue
On Dec 15, 2025, HSCS reported earnings of -0.85 USD per share (EPS) for Q2 26, beating the estimate of -2.01 USD, resulting in a 57.81% surprise. Revenue reached 2.00 thousand, compared to an expected 51.00 thousand, with a -96.08% difference. The market reacted with a -6.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
FAQ
What were HeartSciences Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, HeartSciences Inc. Common Stock reported EPS of -$0.85, beating estimates by 57.81%, and revenue of $2.00K, -96.08% below expectations.
How did the market react to HeartSciences Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -6.48%, changed from $2.47 before the earnings release to $2.31 the day after.
When is HeartSciences Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for HeartSciences Inc. Common Stock's next earnings report?
Based on --
analysts, HeartSciences Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.